Sutro Biopharma (STRO) FCF Margin Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | 7,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,562.00 |
| Sep 30, 2025 | 38,514.00 |
| Jun 30, 2025 | -12,329.00 |
| Mar 31, 2025 | -71,040.00 |
| Dec 31, 2024 | -48,997.00 |
| Sep 30, 2024 | -56,551.00 |
| Jun 30, 2024 | 35,233.00 |
| Mar 31, 2024 | -1,697.00 |
| Dec 31, 2023 | 36,164.00 |
| Sep 30, 2023 | -48,385.00 |
| Jun 30, 2023 | -27,584.00 |
| Mar 31, 2023 | 12,863.00 |
| Dec 31, 2022 | -26,092.00 |
| Sep 30, 2022 | 69,027.00 |
| Jun 30, 2022 | -636.00 |
| Mar 31, 2022 | -38,901.00 |
| Dec 31, 2021 | 16,168.00 |
| Sep 30, 2021 | -29,761.00 |
| Jun 30, 2021 | 12,233.00 |
| Mar 31, 2021 | 4,883.00 |
| Dec 31, 2020 | -10,063.00 |
| Sep 30, 2020 | 730.00 |
| Jun 30, 2020 | 946.00 |
| Mar 31, 2020 | -3,595.00 |
| Dec 31, 2019 | -11,887.00 |
| Sep 30, 2019 | -73,274.00 |
| Jun 30, 2019 | 10,441.00 |
| Mar 31, 2019 | 2,254.00 |
| Dec 31, 2018 | 16,799.00 |